Looking for Glyceryl Monostearate pharmaceutical excipients? Find information on Glyceryl Monostearate's applications, manufacturers, suppliers, etc. on PharmaCompass.

PharmaCompass

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

FINISHED DOSAGE FORMULATIONS

Upload your portfolio for free, ask us

FDA Dossiers

read-more
read-more

01

Dosage Form : SUPPOSITORY

GLYCERYL MONOSTEARATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : SUPPOSITORY

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : RECTAL

CAS :

UNII : 230OU9XXE4

Potency Amount : 35

Potency Unit : MG

blank

02

Dosage Form : LOTION

GLYCERYL MONOSTEARATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : LOTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : TOPICAL

CAS :

UNII : 230OU9XXE4

Potency Amount : 0

Potency Unit : NA

blank

03

Dosage Form : SUSPENSION

GLYCERYL MONOSTEARATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : SUSPENSION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : AURICULAR (OTIC)

CAS : 31566311

UNII : 230OU9XXE4

Potency Amount : 0.5

Potency Unit : %

blank

04

Dosage Form : PASTE

GLYCERYL MONOSTEARATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : PASTE

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : DENTAL

CAS : 31566311

UNII : 230OU9XXE4

Potency Amount : 64

Potency Unit : MG

blank

05

Dosage Form : SUSPENSION

GLYCERYL MONOSTEARATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : SUSPENSION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : OPHTHALMIC

CAS : 31566311

UNII : 230OU9XXE4

Potency Amount : 0.5

Potency Unit : %

blank

06

Dosage Form : CAPSULE, DELAYED ACTION

GLYCERYL MONOSTEARATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, DELAYED ACTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 31566311

UNII : 230OU9XXE4

Potency Amount : 2

Potency Unit : MG

blank

07

Dosage Form : CAPSULE, DELAYED RELEASE

GLYCERYL MONOSTEARATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, DELAYED RELEASE

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 31566311

UNII : 230OU9XXE4

Potency Amount : 1

Potency Unit : MG

blank

08

Dosage Form : CAPSULE, EXTENDED RELEASE

GLYCERYL MONOSTEARATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, EXTENDED RELEASE

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 31566311

UNII : 230OU9XXE4

Potency Amount : 0.25

Potency Unit : MG

blank

09

Dosage Form : CAPSULE, HARD GELATIN

GLYCERYL MONOSTEARATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, HARD GELATIN

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 31566311

UNII : 230OU9XXE4

Potency Amount : 13.75

Potency Unit : MG

blank

10

Dosage Form : CAPSULE, SUSTAINED ACTION

GLYCERYL MONOSTEARATE
arrow
Boulder Peptide 2024
Not Confirmed

Dosage Form : CAPSULE, SUSTAINED ACTION

USA
arrow
Boulder Peptide 2024
Not Confirmed

Route : ORAL

CAS : 31566311

UNII : 230OU9XXE4

Potency Amount : 27

Potency Unit : MG

blank
click full view

EXCIPIENTS BY APPLICATIONS

Click here to find the perfect excipient manufacturers by their capabilities

Co Processed Excipients

read-more
read-more

Solubilizers

read-more
read-more

Topical

read-more
read-more

Coating Systems Additives

read-more
read-more

MARKET PLACE

Do you need sourcing support? Ask us
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty